Filing Flows › Envoy Medical (COCH) › Q2 2026 › vs Q2 2025
Envoy Medical (COCH) Q2 2026 vs Q2 2025 (year over year)
Envoy Medical's revenue fell $27K (-35%) from $78K in Q2 2025 to $51K in Q2 2026.
Envoy Medical, Q2 2026: revenue $51K (-35% year over year), net loss $6.0M, operating cash flow −$5.5M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $51K | $78K | −$27K | -35% |
| Net loss | $6.0M | $5.7M | $292K | +5% |
| Costs & expenses | $6.0M | $5.8M | $265K | +5% |
| Operating costs | $5.6M | $5.1M | $472K | +9% |
| Interest & other, net | $413K | $620K | −$207K | -33% |
| Cost of revenue | $278K | $234K | $44K | +19% |
| Research & development | $3.1M | $2.5M | $647K | +26% |
| Sales & marketing | $181K | $361K | −$180K | -50% |
| General & admin | $2.0M | $2.1M | −$39K | -2% |
| Operating cash sources | $6.0M | $5.7M | $292K | +5% |
| Depreciation | $74K | $85K | −$11K | -13% |
| Share-based compensation | $214K | $146K | $68K | +47% |
| Working capital & other | $238K | $999K | −$761K | -76% |
| Cash used in operations | $5.5M | $4.5M | $996K | +22% |
| Net loss absorbed | $6.0M | $5.7M | $292K | +5% |
Questions
How much did Envoy Medical's revenue grow year over year in Q2 2026?
Envoy Medical's revenue fell $27K (-35%) from $78K in Q2 2025 to $51K in Q2 2026.